389 related articles for article (PubMed ID: 28732519)
21. Bath additives for the treatment of childhood eczema (BATHE): protocol for multicentre parallel group randomised trial.
Santer M; Rumsby K; Ridd MJ; Francis NA; Stuart B; Chorozoglou M; Wood W; Roberts A; Thomas KS; Williams HC; Little P
BMJ Open; 2015 Nov; 5(10):e009575. PubMed ID: 26525422
[TBL] [Abstract][Full Text] [Related]
22. Skin Care and Synbiotics for Prevention of Atopic Dermatitis or Food Allergy in Newborn Infants: A 2 × 2 Factorial, Randomized, Non-Treatment Controlled Trial.
Dissanayake E; Tani Y; Nagai K; Sahara M; Mitsuishi C; Togawa Y; Suzuki Y; Nakano T; Yamaide F; Ohno H; Shimojo N
Int Arch Allergy Immunol; 2019; 180(3):202-211. PubMed ID: 31394530
[TBL] [Abstract][Full Text] [Related]
23. Frequent oil baths and skin barrier during infancy in the PreventADALL study.
Rehbinder EM; Wärnberg Gerdin S; Hoyer A; Bradley M; Lødrup Carlsen KC; Granum B; Hedlin G; Jonassen CM; Leblanc M; Nordlund B; Rudi K; Skjerven HO; Staff AC; Vettukattil R; Söderhäll C
Br J Dermatol; 2024 Jun; 191(1):49-57. PubMed ID: 38446755
[TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial of an emollient with ceramide and filaggrin-associated amino acids for the primary prevention of atopic dermatitis in high-risk infants.
McClanahan D; Wong A; Kezic S; Samrao A; Hajar T; Hill E; Simpson EL
J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2087-2094. PubMed ID: 31287580
[TBL] [Abstract][Full Text] [Related]
25. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.
Pitt M; Garside R; Stein K
Br J Dermatol; 2006 Jun; 154(6):1137-46. PubMed ID: 16704646
[TBL] [Abstract][Full Text] [Related]
26. Does Order of Application of Emollient and Topical Corticosteroids Make a Difference in the Severity of Atopic Eczema in Children?
Ng SY; Begum S; Chong SY
Pediatr Dermatol; 2016; 33(2):160-4. PubMed ID: 26856694
[TBL] [Abstract][Full Text] [Related]
27. A multi-centre, parallel group superiority trial of silk therapeutic clothing compared to standard care for the management of eczema in children (CLOTHES Trial): study protocol for a randomised controlled trial.
Harrison EF; Haines RH; Cowdell F; Sach TH; Dean T; Pollock I; Burrows NP; Buckley H; Batchelor J; Williams HC; Lawton S; Brown SJ; Bradshaw LE; Ahmed A; Montgomery AA; Mitchell EJ; Thomas KS
Trials; 2015 Sep; 16():390. PubMed ID: 26329718
[TBL] [Abstract][Full Text] [Related]
28. TEST (Trial of Eczema allergy Screening Tests): protocol for feasibility randomised controlled trial of allergy tests in children with eczema, including economic scoping and nested qualitative study.
Ridd MJ; Edwards L; Santer M; Chalmers JR; Waddell L; Marriage D; Muller I; Roberts K; Garfield K; Coast J; Selman L; Clement C; Shaw ARG; Angier E; Blair PS; Turner NL; Taylor J; Kai J; Boyle RJ
BMJ Open; 2019 May; 9(5):e028428. PubMed ID: 31076476
[TBL] [Abstract][Full Text] [Related]
29. Skincare interventions in infants for preventing eczema and food allergy: A cochrane systematic review and individual participant data meta-analysis.
Kelleher MM; Cro S; Van Vogt E; Cornelius V; Lodrup Carlsen KC; Ove Skjerven H; Rehbinder EM; Lowe A; Dissanayake E; Shimojo N; Yonezawa K; Ohya Y; Yamamoto-Hanada K; Morita K; Cork M; Cooke A; Simpson EL; McClanahan D; Weidinger S; Schmitt J; Axon E; Tran L; Surber C; Askie LM; Duley L; Chalmers JR; Williams HC; Boyle RJ
Clin Exp Allergy; 2021 Mar; 51(3):402-418. PubMed ID: 33550675
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of Prophylactic Moisturization for Atopic Dermatitis.
Xu S; Immaneni S; Hazen GB; Silverberg JI; Paller AS; Lio PA
JAMA Pediatr; 2017 Feb; 171(2):e163909. PubMed ID: 27918774
[TBL] [Abstract][Full Text] [Related]
31. Protocol for an outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study: the Softened Water for Eczema Prevention (SOFTER) trial.
Jabbar-Lopez ZK; Gurung N; Greenblatt D; Briley A; Chalmers JR; Thomas KS; Frost T; Kezic S; Common JEA; Kong HH; Segre JA; Danby S; Cork MJ; Peacock JL; Flohr C
BMJ Open; 2019 Aug; 9(8):e027168. PubMed ID: 31434765
[TBL] [Abstract][Full Text] [Related]
32. Steroid-Free Over-the-Counter Eczema Skin Care Formulations Reduce Risk of Flare, Prolong Time to Flare, and Reduce Eczema Symptoms in Pediatric Subjects With Atopic Dermatitis.
Weber TM; Samarin F; Babcock MJ; Filbry A; Rippke F
J Drugs Dermatol; 2015 May; 14(5):478-85. PubMed ID: 25942666
[TBL] [Abstract][Full Text] [Related]
33. A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT).
Irvine AD; Jones AP; Beattie P; Baron S; Browne F; Ashoor F; O'Neill L; Rosala-Hallas A; Sach T; Spowart C; Taams L; Walker C; Wan M; Webb N; Williamson P; Flohr C;
Br J Dermatol; 2018 Dec; 179(6):1297-1306. PubMed ID: 29727479
[TBL] [Abstract][Full Text] [Related]
34. Effects of Early Emollient Use in Children at High Risk of Atopic Dermatitis: A German Pilot Study.
Harder I; Stölzl D; Sander N; Hartmann J; Rodriguez E; Mazur C; Kerzel S; Kabesch M; Küster D; Schmitt J; Fölster-Holst R; Gerdes S; Emmert H; Weidinger S
Acta Derm Venereol; 2023 May; 103():adv5671. PubMed ID: 37246806
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema).
Stuart B; Rumsby K; Santer M; Ridd MJ; Francis NA; Chorozoglou M; Spreadbury C; Steele M; Nollett C; Liddiard L; Prude M; Hooper J; Thomas-Jones E; Roberts A; Thomas KS; Williams HC; Little P
Trials; 2018 Oct; 19(1):582. PubMed ID: 30355360
[TBL] [Abstract][Full Text] [Related]
36. Choice of Moisturiser for Eczema Treatment (COMET): feasibility study of a randomised controlled parallel group trial in children recruited from primary care.
Ridd MJ; Garfield K; Gaunt DM; Hollinghurst S; Redmond NM; Powell K; Wilson V; Guy RH; Ball N; Shaw L; Purdy S; Metcalfe C
BMJ Open; 2016 Nov; 6(11):e012021. PubMed ID: 27852708
[TBL] [Abstract][Full Text] [Related]
37. Effects of an emollient application on newborn skin from birth for prevention of atopic dermatitis: a randomized controlled study in Thai neonates.
Techasatian L; Kiatchoosakun P
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):76-83. PubMed ID: 34545646
[TBL] [Abstract][Full Text] [Related]
38. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
[TBL] [Abstract][Full Text] [Related]
39. Comparison of patient (POEM), observer (EASI, SASSAD, TIS) and corneometry measures of emollient effectiveness in children with eczema: findings from the COMET feasibility trial.
Ridd MJ; Gaunt DM; Guy RH; Redmond NM; Garfield K; Hollinghurst S; Ball N; Shaw L; Purdy S; Metcalfe C
Br J Dermatol; 2018 Aug; 179(2):362-370. PubMed ID: 29476542
[TBL] [Abstract][Full Text] [Related]
40. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.
Garside R; Stein K; Castelnuovo E; Pitt M; Ashcroft D; Dimmock P; Payne L
Health Technol Assess; 2005 Jul; 9(29):iii, xi-xiii,1-230. PubMed ID: 16022804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
